Although iron is an essential element for normal cell metabolism, in excess quantities it is highly cytotoxic and lethal. In fact, acute iron poisoning is a leading cause of overdose mortality in young children. Hereditary hemochromatosis, a disorder of iron metabolism, is currently the most prevalent genetic disorder in the world, which results in organ failure and premature mortality. Hence, an enhanced understanding of its pathogenesis is critical for providing safe and effective nursing care to affected individuals and their families. Although the exact mechanism of iron’s toxicity is not known, it was hypothesized that chronic iron loading would result in increased tissue (heart, liver, and spleen) concentrations of iron and increased free radical production in a murine model (n = 20). Our results show that chronic iron loading results in highly significant dose-dependent increases in tissue concentrations of iron and systemic free radical generation (p < 0.001).
Get full access to this article
View all access options for this article.
References
1.
Ball, A. , & Sole, M. J. (1998). Oxidative stress and the pathogenesis of heart failure. Cardiology Clinics, 16, 665-675.
2.
Bartfay, W. J. , & Bartfay, E. (in press). Iron-overload cardiomyopathy: Evidence for a free radical-mediated mechanism of injury and dysfunction in a murine model. Biological Research for Nursing.
3.
Bartfay, W. J. , Butany, J., Lehotay, D. C., Sole, M. J., Hou, D., Bartfay, E., & Liu, P. P. (1999). A biochemical, histochemical, and electron microscopic study on the effects of iron-loading on the hearts of mice. Cardiovascular Pathology, 8(6), 305-314.
4.
Bartfay, W. J. , Dawood, F., Wen, W. H., Lehotay, D. C., Hou, D., Bartfay, E., Luo, X. P., Backx, P. H., & Liu, P. P. (1999). Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovascular Research, 43, 892-900.
5.
Bartfay, W. J. , Hou, D., Brittenham, G. M., Bartfay, E., Sole, M. J., Lehotay, D. C., & Liu, P. P. (1998). The synergistic effects of vitamin E and selenium in iron-loaded mouse hearts. Canadian Journal of Cardiology, 14, 937-941.
6.
Bartfay, W. J. , Hou, D., Lehotay D. C., Luo, X., Bartfay, E., Backx, P. H., & Liu, P. P. (2000). Cytotoxic aldehyde generation in heart following acute iron-loading. Journal of Trace Elements, Biology and Medicine, 14(1), 14-20.
7.
Bartfay, W. J. , Sher, G. D., Lehotay, D. C., Bartfay, E., Tyler, B., Luo, X. P., & Liu, P. P. (1999). Comparison of cytotoxic aldehydes in beta-thalassemia patients chelated with deferoxamine or deferiprone (L1) versus no chelation. Hematology, 4, 67-76.
8.
Cheeseman, K. H. (1993). Mechanisms and effects of lipid peroxidation. Molecular Aspects of Medicine, 14, 191-197.
9.
Chyka, P. A. , Butler, A. Y., & Holley, J. E. (1996). Serum iron concentrations and symptoms of acute iron poisoning in children. Pharmacotherapy, 16, 1053-1058.
10.
Esterbauer, H. (1993). Cytotoxicity and genotoxicity of lipid-peroxidation products. American Journal of Clinical Nutrition, 57, 779S-786S.
11.
Feder, J. N. , Gnirke, A., & Thomas, W. (1996). A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
12.
Gutteridge, J.M.C. (1993). Free radicals in disease processes: A complication of cause and consequence. Free Radical Research, 19, 141-158.
13.
Halliwell, B. (1997). Antioxidants and human disease: A general introduction. Nutrition Reviews, 55, S44-S52.
14.
Hentze, M. W. , & Kuhn, L. C. (1996). Molecular control of vertebral iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proceedings of the National Academy of Science, 93, 8175-8182.
15.
Konz, K. H. , Haap, M., Walsh, R. A., Burk, R. F., & Seipel, L. (1991). Selenium as a protector of diastolic function during oxidative stress. Journal of Trace Elements, Electrolytes, Health and Disease, 5, 87-93.
16.
Lesnefsky, E. J. (1994). Tissue iron-overload and mechanisms of iron-catalyzed oxidative injury. Advances in Experimental Medical Biology, 366, 129-146.
17.
Liu, P. , & Olivieri, N. (1994). Iron-overload cardiomyopathies: New insights into an old disease. Cardiovascular Drugs and Therapy, 8, 101-110.
18.
Livrea, M. A. , Tesoriere, L., Pinaudi, A. M., Calabrese, A., Maggio, A., Freisleben, H. J., D-Arpa, D., D’Anna, R., & Bongiorno, A. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: Iron-overload and depletion of lipid soluble antioxidants. Blood, 88, 3608-3614.
19.
Luo, X. P. , Yazdanpanah, M., Bhooi, N., & Lehotay, D. C. (1995). Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Annals of Biochemistry, 228, 294-298.
20.
Lynch, S. R. (1995). Iron-overload: Prevalence and impact on health. Nutrition Reviews, 53, 255-260.
21.
McCord, J. M. (1996). Effects of positive iron status at a cellular level. Nutrition Reviews, 54, 85-88.
22.
Montgomery, D. C. (1991). Design and analysis of experiments (3rd ed.). Toronto: John Wiley.
23.
Morse, S. B. , Hardwick, W. E., Jr., & King, W. D. (1997). Fatal iron intoxication in an infant. South Medical Journal, 90, 1043-1047.
24.
Olfert, E. D. , Cross, B. M., & McWilliams, A. A. (1993). Canadian Council on Animal Care: Guide to the use of experimental animals (2nd ed.). Ottawa, Ontario: Bradda Printing Services.
25.
Olivieri, N. F. , & Brittenham, G. M. (1997). Iron-chelating therapy and the treatment of Thalassemia. Blood, 89, 281-284.
26.
Pantopoulos, K. , & Hentze, M. W. (1995). Nitric oxide signalling to iron-regulatory protein: Direct control of ferritin mRNA translation receptor mRNA stability in transfected fibro-blasts. Proceedings of the National Academy of Science, 92, 1267-1271.
27.
Parkkila, S. , Niemela, O., Britton, R. S., Brown, K. E., & Yla-Herttuala, S. (1996). Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron-overload. American Journal of Physiology, 270, G376-G338.
28.
Young, I. S. , Trouton, T. G., Torney, J. J., McMaster, D., Callender, M., & Trimble, E. R. (1994). Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radical Biology and Medicine, 16, 393-397.
